---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-206578"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:13:43.553826+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q1 2026 sales $66.6M (+11%), EPS $0.68 (+42%); raises FY guidance

## Summary
- Q1 sales $66.6M (up 11% YoY, 10% organic); gross margin 72.7% (+350 bps); EPS $0.68 (+42%).
- Operating income $17.8M (+41%), op margin 27%; cash grew to $367.2M.
- Artegraft grew 36% worldwide; records for grafts (+20%), valvulotomes (+15%), carotid shunts (+11%).
- Quarterly dividend $0.25/share (payable June 4, record May 21); $100M share repurchase program active.
- FY 2026 guidance: sales $277-283M (mid $280M, +12%), EPS $2.93-3.08 (mid $3.00, +26% adj.).

## SEC filing metadata
- accession: 0001193125-26-206578
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/d94324d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-206578
- JSON: https://secwatch.observer/filing/0001193125-26-206578.json
- Plain text: https://secwatch.observer/filing/0001193125-26-206578.txt

## Source-grounded claims
- claim_id: 18b35d6c4513f555ea14b7ef317f17e8fb286c74
  claim: LEMAITRE VASCULAR INC reported Q2 2026 results: revenue $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.), EPS $0.79 - $0.84 (Mid $0.81, +35%.). Guidance raised.
  evidence_excerpt: Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm
- claim_id: f53febc1b2bffe65d2039bcc7def7b2fece6e669
  claim: LEMAITRE VASCULAR INC reported Q1 2026 results: revenue Sales $66.6mm, EPS EPS $0.68.
  evidence_excerpt: LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. Q1 2026: • Sales $66.6mm, +11% (+10% organic) vs. Q1 2025 • Gross margin 72.7% (+350 bps) • Op. income $17.8mm (+41%) • Op. margin 27% • EPS $0.68 (+42%) • Cash up $8.1mm sequentially to $367.2mm
  evidence_url: https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.